In January 2025, the FDA approved semaglutide for kidney disease risk reduction in type 2 diabetes patients with CKD, and in late 2025 approved oral Wegovy (semaglutide 25 mg tablet) as the first GLP-1 pill for weight management ( [19] )
Knowing the molecule helps you check that you are getting the right medicine at the right dose
Frequent need for antidiarrhoeal medication suggests the need for medical review and possible treatment adjustment
L-Carnitina: cos, a cosa serve, benefici, dosaggio e quando assumerla Quando si parla di L-Carnitina facile fare confusione, per questo motivo vogliamo chiarire ogni tuo dubbio una volta per tutte
Phase 3 trial data has now demonstrated weight loss outcomes that, in some patient groups, approach those previously only achieved through bariatric surgery
The elimination half-life of the intact GLP-1, including the DPP-4-generated metabolites, such as GLP-1 [936] or GLP-1 [937]) is 2 min